These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2189272)

  • 1. [Restenosis following coronary dilatation].
    Leisch F
    Wien Med Wochenschr; 1990 Mar; 140(5):131-3. PubMed ID: 2189272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Restenosis after percutaneous transluminal coronary angioplasty].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(17):513-5. PubMed ID: 2350767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restenosis and arterial remodelling after coronary angioplasty].
    Jørgensen B; Forfang K
    Tidsskr Nor Laegeforen; 1996 Aug; 116(20):2460-3. PubMed ID: 8928109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
    Hombach V; Waltenberger J; Voisard R; Höher M
    Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standards in interventional therapy of coronary artery disease].
    Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G
    Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restenosis after percutaneous transluminal coronary angioplasty and its prevention].
    Przewłocka-Kosmala M; Kosmala W
    Przegl Lek; 1999; 56(10):671-5. PubMed ID: 10695384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stents without restenosis--true or a myth?].
    Starcević B; Vagić JS
    Acta Med Croatica; 2004; 58(2):143-6. PubMed ID: 15208801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coronary restenosis. An unresolved problem of percutaneous transluminal coronary angioplasty].
    Iñíguez Romo A
    Rev Esp Cardiol; 1993; 46 Suppl 3():85-96. PubMed ID: 8303057
    [No Abstract]   [Full Text] [Related]  

  • 12. Restenosis: the clinical problem.
    Holmes DR; Schwartz RS
    Coron Artery Dis; 1993 Mar; 4(3):229-31. PubMed ID: 8269216
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
    Waksman R; Kosinski AS; Klein L; Boccuzzi SJ; King SB; Ghazzal ZM; Weintraub WS
    Am J Cardiol; 1996 Jul; 78(2):221-4. PubMed ID: 8712148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril for prevention of restenosis after coronary angioplasty.
    Kaul U; Chandra S; Bahl VK; Sharma S; Wasir HS
    Indian Heart J; 1993; 45(6):469-73. PubMed ID: 8070823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical interventions for prevention and therapy of restenosis of coronary heart disease].
    Schanzenbächer P
    Verh Dtsch Ges Inn Med; 1991; 97():593-7. PubMed ID: 1808952
    [No Abstract]   [Full Text] [Related]  

  • 16. Marine lipids and coronary angioplasty. Benefit or risk.
    Sipperly ME
    Prog Cardiovasc Nurs; 1989; 4(4):119-23. PubMed ID: 2690063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors].
    Sakai Y; Tomobuchi Y; Hashizume T; Imanishi T; Tomimoto S; Toyoda Y; Arita M; Hano T; Nishio I
    J Cardiol; 1997 Jan; 29(1):1-6. PubMed ID: 9023673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis.
    Gapinski JP; VanRuiswyk JV; Heudebert GR; Schectman GS
    Arch Intern Med; 1993 Jul; 153(13):1595-601. PubMed ID: 8323422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary brachytherapy: an evolving modality for treatment of restenosis following percutaneous coronary intervention.
    Srinivas VS; Williams DO; Chougale P; Shearer D
    Med Health R I; 2001 Feb; 84(2):51-4. PubMed ID: 11272660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.